Advent sells Romanian pharma for $324m
India’s Ranbaxy Laboratories, unsuccessful in its bid for 3i’s German pharma business betapharm in February, has paid $324m for Advent International-backed Terapia.
India’s Ranbaxy Laboratories, unsuccessful in its bid for 3i’s German pharma business betapharm in February, has paid $324m for Advent International-backed Terapia.
Copyright PEI Media
Not for publication, email or dissemination